vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and loanDepot, Inc. (LDI). Click either name above to swap in a different company.
loanDepot, Inc. is the larger business by last-quarter revenue ($310.3M vs $207.8M, roughly 1.5× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -7.2%, a 64.6% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-648.0M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
IDYA vs LDI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $310.3M |
| Net Profit | $119.2M | $-22.5M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | -10.3% |
| Net Margin | 57.4% | -7.2% |
| Revenue YoY | — | 20.5% |
| Net Profit YoY | 330.1% | 32.4% |
| EPS (diluted) | $1.33 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $310.3M | ||
| Q3 25 | $207.8M | $323.3M | ||
| Q2 25 | — | $282.5M | ||
| Q1 25 | — | $273.6M | ||
| Q4 24 | — | $257.5M | ||
| Q3 24 | $0 | $314.6M | ||
| Q2 24 | $0 | $265.4M | ||
| Q1 24 | $0 | $222.8M |
| Q4 25 | — | $-22.5M | ||
| Q3 25 | $119.2M | $-4.9M | ||
| Q2 25 | — | $-13.4M | ||
| Q1 25 | — | $-21.9M | ||
| Q4 24 | — | $-33.2M | ||
| Q3 24 | $-51.8M | $1.4M | ||
| Q2 24 | $-52.8M | $-32.2M | ||
| Q1 24 | $-39.6M | $-34.3M |
| Q4 25 | — | -10.3% | ||
| Q3 25 | 52.2% | -3.2% | ||
| Q2 25 | — | -11.4% | ||
| Q1 25 | — | -16.8% | ||
| Q4 24 | — | -32.7% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | -29.1% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | — | -7.2% | ||
| Q3 25 | 57.4% | -1.5% | ||
| Q2 25 | — | -4.7% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | — | -12.9% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | -12.1% | ||
| Q1 24 | — | -15.4% |
| Q4 25 | — | — | ||
| Q3 25 | $1.33 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.60 | $0.01 | ||
| Q2 24 | $-0.68 | $-0.18 | ||
| Q1 24 | $-0.53 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $337.2M |
| Total DebtLower is stronger | — | $2.1B |
| Stockholders' EquityBook value | $1.1B | $386.0M |
| Total Assets | $1.2B | $6.9B |
| Debt / EquityLower = less leverage | — | 5.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $337.2M | ||
| Q3 25 | $786.9M | $459.2M | ||
| Q2 25 | — | $408.6M | ||
| Q1 25 | — | $371.5M | ||
| Q4 24 | — | $421.6M | ||
| Q3 24 | $920.0M | $483.0M | ||
| Q2 24 | $701.7M | $533.2M | ||
| Q1 24 | $698.8M | $603.7M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | — | $386.0M | ||
| Q3 25 | $1.1B | $433.3M | ||
| Q2 25 | — | $439.1M | ||
| Q1 25 | — | $469.3M | ||
| Q4 24 | — | $506.6M | ||
| Q3 24 | $1.2B | $592.0M | ||
| Q2 24 | $931.7M | $578.9M | ||
| Q1 24 | $935.3M | $637.3M |
| Q4 25 | — | $6.9B | ||
| Q3 25 | $1.2B | $6.2B | ||
| Q2 25 | — | $6.2B | ||
| Q1 25 | — | $6.4B | ||
| Q4 24 | — | $6.3B | ||
| Q3 24 | $1.2B | $6.4B | ||
| Q2 24 | $973.7M | $5.9B | ||
| Q1 24 | $961.5M | $6.2B |
| Q4 25 | — | 5.44× | ||
| Q3 25 | — | 4.83× | ||
| Q2 25 | — | 4.70× | ||
| Q1 25 | — | 4.30× | ||
| Q4 24 | — | 4.00× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | — | 3.41× | ||
| Q1 24 | — | 3.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $-638.7M |
| Free Cash FlowOCF − Capex | $142.2M | $-648.0M |
| FCF MarginFCF / Revenue | 68.4% | -208.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-734.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-638.7M | ||
| Q3 25 | $142.2M | $43.4M | ||
| Q2 25 | — | $67.6M | ||
| Q1 25 | — | $-179.9M | ||
| Q4 24 | — | $47.7M | ||
| Q3 24 | $-49.2M | $-349.2M | ||
| Q2 24 | $-32.9M | $-278.3M | ||
| Q1 24 | $-43.8M | $-278.5M |
| Q4 25 | — | $-648.0M | ||
| Q3 25 | $142.2M | $38.7M | ||
| Q2 25 | — | $61.4M | ||
| Q1 25 | — | $-186.7M | ||
| Q4 24 | — | $40.8M | ||
| Q3 24 | $-49.7M | $-356.4M | ||
| Q2 24 | $-33.9M | $-285.7M | ||
| Q1 24 | $-45.1M | $-283.3M |
| Q4 25 | — | -208.9% | ||
| Q3 25 | 68.4% | 12.0% | ||
| Q2 25 | — | 21.7% | ||
| Q1 25 | — | -68.2% | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | — | -113.3% | ||
| Q2 24 | — | -107.7% | ||
| Q1 24 | — | -127.2% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -255.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
